Anavex Life Sciences (AVXL) Return on Equity [ROE] (2014 - 2026)
Anavex Life Sciences' Return on Equity [ROE] was -14.85% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 40.00 percentage points from -54.85% a year earlier and up 16.22 percentage points from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Equity [ROE] at Anavex Life Sciences came in at -47.79%, down 14.98 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +62.80 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Equity [ROE] was -32.81% in FY2024 (+0.60 pp), -33.41% in FY2023 (-0.69 pp), -32.72% in FY2022 (+9.87 pp) and -42.58% in FY2021 (+68.01 pp).
- The fiscal Q3 2026 figure marks the highest quarterly Return on Equity [ROE] in data going back to fiscal Q4 2017.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of -2.05 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q4 2021 (a gain of 76.57 percentage points); the worst was fiscal Q3 2025 (a drop of 23.53 percentage points).
- Per Business Quant data, AVXL's Return on Equity [ROE] in the three fiscal quarters before Q3 2026 was -31.08% (Q2 2026), -40.29% (Q1 2026) and -55.33% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Anavex Life Sciences | 104.75 Mn | -375.33 Mn | - | -11.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.99% |
| Mar 31, 2026 | -28.27% |
| Dec 31, 2025 | -36.99% |
| Sep 30, 2025 | -51.01% |
| Jun 30, 2025 | -50.64% |
| Mar 31, 2025 | -44.93% |
| Dec 31, 2024 | -40.20% |
| Sep 30, 2024 | -34.31% |
| Jun 30, 2024 | -31.30% |
| Mar 31, 2024 | -29.83% |
| Dec 31, 2023 | -31.01% |
| Sep 30, 2023 | -32.90% |
| Jun 30, 2023 | -35.28% |
| Mar 31, 2023 | -37.57% |
| Dec 31, 2022 | -36.08% |
| Sep 30, 2022 | -32.68% |
| Jun 30, 2022 | -28.92% |
| Mar 31, 2022 | -26.52% |
| Dec 31, 2021 | -24.83% |
| Jun 30, 2021 | -27.94% |
API Access
Anavex Life Sciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();